1. LENALIDOMIDE AND OBINUTUZUMAB WITH CHOP FOR NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA: PHASE I/II RESULTS. (June 2017) Authors: Westin, J.R.; Oki, Y.; Nastoupil, L.; Fayad, L.; Neelapu, S.; Turturro, F.; Hagemeister, F.B.; Rodriguez, A.; Lee, H.J.; Young, K.H.; McDonnell, T.; Ford, R.; Davis, R.E. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. TREATMENT WITH COMBINATION OF LENALIDOMIDE AND RITUXIMAB ACHIEVES DURABLE RESPONSES IN A LONG TERM FOLLOW UP OF PATIENTS WITH INDOLENT NON‐HODGKIN'S LYMPHOMA. (June 2017) Authors: Chaudhry, M.; Nastoupil, L.; Samaniego, F.; Neelapu, S.S.; Hagemeister, F.B.; Fanale, M.A.; Fayad, L.; Westin, J.R.; Oki, Y.; Feng, L.; Fowler, N. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗